Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai, Inc. (MRAI) is a technology platform company whose subsidiaries provide Third-Party Administration (TPA), Pharmacy Benefit Management (PBM) and value-oriented health plan services to employers that directly pay for employee health benefits. This news page aggregates company-issued updates and related coverage so readers can follow how Marpai describes its progress in the self-funded employer health plan market.
Recent Marpai news has focused on its turnaround strategy, cost discipline and operational efficiency, as well as developments in its TPA and PBM offerings. The company has reported reductions in operating expenses and changes in operating loss and net loss over multiple quarters, and it links these trends to efforts to streamline operations and adjust its business model. News releases also highlight private placements and other capital transactions disclosed in Form 8-K filings, which Marpai states are intended to support working capital and general corporate purposes.
Marpai’s updates describe initiatives such as the Marpai Saves program and the relaunch of MarpaiRx, its PBM solution, which the company positions as part of its approach to serving self-funded employer health plans. Other announcements discuss network access agreements, including access to the Aetna Signature Administrator PPO network, and the addition of tools like the Aetna Faircost Optimizer for managing out-of-network claims costs.
Investors and observers can use this news feed to review Marpai’s own descriptions of its financial results, strategic initiatives, technology platform developments and capital raising activities. For a fuller picture, readers may compare these news items with the company’s SEC filings and other official disclosures.
Marpai (OTCQX: MRAI), a healthcare technology and Third-Party Administration (TPA) services provider, has appointed Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. Scrip brings extensive experience in scaling private equity and venture capital-owned companies, with expertise in healthcare consumer services, employers, providers, and payor markets.
The strategic hire aims to accelerate Marpai's profitable growth and enhance operational excellence. CEO Damien Lamendola emphasized that Scrip's appointment is crucial for the company's journey towards sustainable growth, citing his proven track record in complex healthcare environments and deep understanding of the TPA landscape.
Marpai Inc. (OTCQX: MRAI), a healthcare technology and Third-Party Administration (TPA) services provider, has scheduled its Q1 2025 earnings conference call for May 15, 2025, at 8:30 a.m. ET. The company will release its first quarter 2025 financial results on Wednesday, May 14, after market close.
The conference call will be accessible via phone (US: 1-646-357-8785 / Toll Free: 1-800-836-8184) and webcast. A replay will be available at the same webcast URL within 2 hours after the call ends and will remain accessible until May 22, 2025. The telephonic replay can be accessed using the code 37963#.
Marpai Inc (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA) for self-funded employer health plans, has announced its participation in the Planet MicroCap Showcase: VEGAS 2025.
The company's presentation is scheduled for Wednesday, April 23, 2025, at 5:30 PM PST. CEO Damien Lamendola and CFO Steve Johnson will lead the presentation and conduct a Q&A session. The event will be held at the Paris Hotel & Casino in Las Vegas, NV.
Investors can attend the live presentation through a webcast and schedule one-on-one meetings with Marpai's management on Thursday, April 24, 2025. The conference is being organized in partnership with MicroCapClub, and registration is required for both the presentation and individual meetings.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), announced its Q4 and full year 2024 financial results. Q4 2024 showed mixed results with net revenues of $6.6M (6% decrease from Q3), while net loss improved by 67.5% year-over-year to $1.2M.
For Full Year 2024, the company reported net revenues of $28.2M (24.2% decrease YoY), but demonstrated significant improvements in losses. Operating loss decreased by 21.1% to $22.1M, while Adjusted EBITDA loss improved to $9.1M from $20.2M in 2023.
CEO Damien Lamendola highlighted the company's turnaround efforts, announcing plans to introduce PBM-based products in H2 2025. The company aims to achieve profitability in 2025 through continued cost streamlining and innovative services like the Empara Member Engagement Portal.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has announced it will host a conference call and webcast on March 27, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results.
The company, which aims to transform the $22 billion TPA market through affordable, intelligent healthcare solutions for self-funded employer health plans, will release its Q4 and full year 2024 results on Wednesday after market close. A webcast replay will be available at the same URL within 2 hours of the call's conclusion and accessible until April 3, 2025.
Marpai (OTCQX: MRAI), a technology platform company in the $22 billion Third-Party Administrator market, has announced a strategic collaboration with Empara to transform self-funded employer health plans. The partnership includes the immediate implementation of Empara's Health Engagement Platform.
The new unified platform will consolidate multiple fragmented tools, apps, and portals into a streamlined solution featuring a member app, partner console, and marketplace. The integration aims to enhance benefit utilization and cost control while improving user experience for plan members and administrators.
According to John Powers, Marpai's President, the full platform is expected to be operational by the end of Q2 2025, marking a significant step in the company's TPA evolution.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has secured an additional $5 million in non-dilutive funding from JGB Collateral This follows their previous agreement from April 16, 2024, where they sold Senior Secured Convertible Debentures worth $11.83 million for $11 million.
Of the new $5 million funding, $2 million was delivered at closing, with the remaining $3 million held in escrow pending certain conditions. Unlike the original investment, the conversion feature does not apply to these new debentures. The company plans to use the proceeds for growth initiatives and working capital. ThinkEquity served as an advisor for this financing.
Marpai (OTCQX: MRAI), a technology platform company operating as a national Third-Party Administrator (TPA), has announced the pricing of a $700,000 private placement. The offering consists of 621,194 shares of Class A common stock at $1.13 per share, for total gross proceeds of $701,950. The investors include an institutional fund and company officers and directors. The closing is expected by December 6, 2024.
The company plans to use the net proceeds for general working capital. The securities are exempt from registration requirements under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Marpai, a technology platform company operating as a national Third-Party Administrator (TPA), has announced several key developments for Q4. The company has secured major new clients for 2025, including a 4,000-employee restaurant group, a 6,000-employee hospital group, and housing industry clients with approximately 3,400 employees. Marpai, which operates in the $22 billion TPA market, remains on track for expected break-even performance in early 2025, supported by these new sales and ongoing efficiency improvements.
Marpai (OTCQX: MRAI) reported Q3 2024 financial results showing mixed performance in its turnaround efforts. Net revenues were $7.0 million, down 20% year-over-year. Operating expenses decreased by 36% to $10.1 million, while operating loss improved by 57% to $3.1 million. Net loss decreased by 51% to $3.6 million, with basic and diluted earnings per share at ($0.30), an improvement of $0.68 per share year-over-year. The company, which operates as a Third-Party Administrator in the $22 billion TPA market, plans to announce new developments in Q4 2024.